Find Clinical Trial

Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer


← Back
Study Phase

Phase 1

Therapeutic Area

Cancers

Active substance/
Medical device

TRIFLURIDINE, TIPIRACIL

SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active Substance CodeS095005
Protocol CodeCL1-95005-001
EudraCT Code2015-004894-34
NCT CodeNCT02848443
ISRCTN CodeISRCTN15566373


Documents and links

Results are not yet available.




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.
Accessibility